MichelleKatsumiZimmermanMD

Pathology • Indianapolis, IN

Chemical Pathology, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology & Laboratory Medicine, Indiana University School of Medicine

Join to view full profile

Dr. Zimmerman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zimmerman's full profile

Already have an account?

Office
350 W 11th St
Rm 5046
Indianapolis, IN 46202
Phone+1 317-491-6558

Fax+1 317-491-6114

Education & Training

Corewell Health East Beaumont (Royal Oak)Fellowship, Chemical Pathology, 2010 - 2011
San Antonio Uniformed Services Health Education ConsortiumResidency, Pathology-Anatomic and Clinical, 2002 - 2006
San Antonio Uniformed Services Health Education ConsortiumInternship, Internal Medicine, 1998 - 1999
Perelman School of Medicine at the University of PennsylvaniaClass of 1998

Certifications & Licensure

MI State Medical License 2010 - 2026
VA State Medical License 1999 - 2026
IN State Medical License 2011 - 2025
TX State Medical License 2008 - 2018
OH State Medical License 2005 - 2006
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Pathology - Chemical

Publications & Presentations

PubMed

1 citations
Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern.
Amanda J Griffin, Kyle L O'Donnell, Kyle Shifflett, John-Paul Lavik, Patrick M Russell
Scientific Reports. 2022-03-10
1 citations
Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern
Amanda J. Griffin, K. L. Oa Donnell, Kyle Shifflett, J. P. Lavik, Patrick M Russell
Biorxiv. 2021-11-12
26 citations
Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19.
Fahim Syed, Wei Li, Ryan F. Relich, Patrick M Russell, Shanxiang Zhang
The Journal of Infectious Diseases. 2021-04-22